{{Short description|Japanese pharmaceutical company}}
{{Infobox company
...
7 KB (452 words) - 12:39, 21 November 2023
|[[Takeda Pharmaceutical Company]]
|[[Mochida Pharmaceutical]]
...
8 KB (294 words) - 10:25, 16 April 2024
* [[Linagliptin/ja|リナグリプチン]]（2011年FDA承認、[[Eli Lilly and Company]]と[[Boehringer Ingelheim]]によりトラジェンタとして販売されている）
* [[Anagliptin/ja|アナグリプチン]]（日本では2012年にスイニーとして承認され、株式会社三和化学研究所と[[Kowa (company)|興和株式会社]]が販売している）
...
8 KB (243 words) - 19:57, 12 March 2024
...pean Medicines Agency|欧州医薬品庁]]からフェブキソスタットの販売承認を取得し、[[Takeda Pharmaceutical Company|武田薬品工業]]は2009年2月にFDAの承認を取得、帝人は2011年に日本の当局から承認を取得した。Ipsenは2009年に[[Menarini]]
[[Category:Drugs developed by Takeda Pharmaceutical Company]]
...
11 KB (519 words) - 20:40, 22 April 2024
...ave been shortened in a number of cases, so that if the article title of a company is "XYZ Pharma", for instance, the entry will appear here as "XYZ".
...stries (ACI)|Advanced Chemical Industries]] (conglomerate which includes a pharmaceutical subsidiary; 1968– )
...
14 KB (1,132 words) - 12:42, 6 January 2023
...in people with a history of [[cardiovascular]] diseases. The FDA required Takeda to conduct this safety study when the medicine was approved in 2009. The fe
Febuxostat was discovered by scientists at the Japanese pharmaceutical company [[Teijin]] in 1998. Teijin partnered the drug with [[TAP Pharmaceuticals]]
...
9 KB (1,260 words) - 20:24, 22 April 2024
...in people with a history of [[cardiovascular]] diseases. The FDA required Takeda to conduct this safety study when the medicine was approved in 2009. The fe
Febuxostat was discovered by scientists at the Japanese pharmaceutical company [[Teijin]] in 1998. Teijin partnered the drug with [[TAP Pharmaceuticals]]
...
9 KB (1,308 words) - 20:19, 22 April 2024
{{Infobox company
| name = Kobayashi Pharmaceutical Co., Ltd.
...
29 KB (537 words) - 11:48, 22 November 2023
...agliptin]] (FDA approved in 2011, marketed as Tradjenta by [[Eli Lilly and Company]] and [[Boehringer Ingelheim]])
...12, marketed by Sanwa Kagaku Kenkyusho Co., Ltd. and [[Kowa (company)|Kowa Company, Ltd.]])
...
6 KB (770 words) - 17:34, 12 March 2024
...agliptin]] (FDA approved in 2011, marketed as Tradjenta by [[Eli Lilly and Company]] and [[Boehringer Ingelheim]])
...12, marketed by Sanwa Kagaku Kenkyusho Co., Ltd. and [[Kowa (company)|Kowa Company, Ltd.]])
...
6 KB (812 words) - 17:34, 12 March 2024
|[[Takeda Pharmaceutical Company]]
|[[Mochida Pharmaceutical]]
...
6 KB (772 words) - 10:25, 16 April 2024
|[[Takeda Pharmaceutical Company]]
|[[Mochida Pharmaceutical]]
...
6 KB (794 words) - 10:24, 16 April 2024
{{Short description|British-Swedish pharmaceutical company}}
{{Infobox company
...
40 KB (1,603 words) - 14:32, 24 August 2023
...al agonist activity. A group at DuPont postulated that both Ang II and the Takeda leads were bound at the same receptor site. These two substances served as
...the spatial structure of Ang II, scientists at DuPont discovered that the Takeda structures had to be enlarged at a particular position to resemble more clo
...
22 KB (3,221 words) - 10:25, 28 March 2024
...al agonist activity. A group at DuPont postulated that both Ang II and the Takeda leads were bound at the same receptor site. These two substances served as
...the spatial structure of Ang II, scientists at DuPont discovered that the Takeda structures had to be enlarged at a particular position to resemble more clo
...
22 KB (3,315 words) - 10:25, 28 March 2024
...([https://pins.japic.or.jp/pdf/newPINS/00002835.pdf PI]) ([https://www.med.takeda-teva.com/di-net/product/doc/1/02/1102_CALSLOT_tab_IF.pdf IF])
|[[Takeda Pharmaceutical Company|武田薬品工業]]
...
27 KB (1,306 words) - 15:19, 11 November 2023
[[Takeda Pharmaceutical Company|武田薬品]]の研究者らは1982年に1-[[Benzimidazole/ja|ベンジルイミダゾール]]-5-酢酸誘導体のグループから弱い非ペプチド性の
...
27 KB (998 words) - 12:39, 28 March 2024
...ate]] them, or alleviate [[symptom]]s. [[List of pharmaceutical companies|Pharmaceutical companies]] may deal in [[Generic drug|generic]] or [[brand]] medications a
The modern era of pharmaceutical industry began with local apothecaries that expanded from their traditional
...
60 KB (8,551 words) - 22:13, 8 January 2023
[[Alogliptin/ja|アログリプチン]]（''図9''）は、[[Takeda Pharmaceutical Company|武田薬品工業]]によって開発された新規の[[DPP-4 inhibitor/ja|DPP-4阻害薬]]である。研究者らは、[[quinazolinon
...
41 KB (1,558 words) - 17:16, 12 March 2024
...([https://pins.japic.or.jp/pdf/newPINS/00002835.pdf PI]) ([https://www.med.takeda-teva.com/di-net/product/doc/1/02/1102_CALSLOT_tab_IF.pdf IF])
|[[Takeda Pharmaceutical Company|武田薬品工業]]
...
23 KB (2,941 words) - 15:18, 11 November 2023